We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel (ANTARCTIC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01538446
First Posted: February 24, 2012
Last Update Posted: January 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Eli Lilly and Company
Daiichi Sankyo, Inc.
Allies in Cardiovascular Trials Initiatives and Organized
Accumetrics, Inc.
Stentys
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):